Anemia
46 - 56 of
56 Results
Sort Results:
Article:
Fewer patients will be receiving the erythropoiesis-stimulating agents (ESAs) Procrit, Epogen, and Aranesp
June 2007
Guideline:
2007 Science Advisory on Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients with Coronary Artery Stents
February 2007
Guideline:
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
February 2007
Article:
Aranesp (darbepoetin alfa), the new longer-acting erythropoietin analog for anemia
November 2001